chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Lethargy; Fever ranging from 99-101; Diarrhea; Nausea; Headache; Minor arm swelling; Dose 1: 22Feb2021Dose 2: 12Apr2021; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 12Apr2021 at 11:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included bradycardia episode, minor osteoarthritis, osteoporosis and anxiety. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lorazepam (MANUFACTURER UNKNOWN) for anxiety from an unknown date and unknown if ongoing. The patient previously took lidocaine (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy (reported as tested and confirmed). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the right arm on 22Feb2021 at 14:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. On 12Apr2021, within 12 hours of vaccination, the patient experienced minor arm swelling. On 13Apr2021 at 02:00, the patient experienced lethargy, fever ranging from 99-101 (unspecified units), diarrhea, nausea and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the events minor arm swelling, lethargy, fever ranging from 99-101, diarrhea, nausea and headache was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Patient received the second dose of COVID shot and passed out about 5 minutes following administration. Patient regained consciousness within 30 seconds and then felt nauseous. Paramedics were called but patient refused to be taken to ER via ambulance. Checked in with patient's husband that afternoon and he said she was feeling fine.
Telephone call received from client who reports she received vaccine yesterday and is now  having a sore arm and pressure in her ears.  Also stated she had sinus infection for a month.  Having buzzing in her ears but not sure if buzzing  or "shot:.  Stated at work at time of this report and just wanted to report.
Red circle around injection site approximately 2 inches in diameter.  Vomiting, fever, general feeling of malaise.  Patient has Rett syndrome and is severely/multiply disabled.  She never vomits and she did twice after vaccine.
Per dad, at site of Hib and DTAP vaccines, child had a knot the size of 1/2 dollar and slightly warm to touch. Child active, alert, playful and walking fine. No stiffness. Instructed to use warm cloths to area and Motrin. Call if no improvement, changes in signs and symptoms or condition worsens or any other concerns or questions.
positive COVID-19 test with symptoms; positive COVID-19 test with symptoms; This is a spontaneous report from a contactable nurse, who is also the patient. This 31-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in Dec2020 at single dose for COVID-19 immunisation. Relevant medical history and concomitant medications were not reported. The reporting nurse stated that she received her first dose of the COVID-19 vaccine on Saturday (e.g. Dec2020). She had taken a PCR test on Thursday and received a negative result on Saturday, the same day she received her vaccination. She reported developing a fever on Monday night and testing positive for COVID-19 on Tuesday. At the time of the report, the outcome of the events was unknown.  The information about lot/batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspect vaccine BNT162B2 in this patient cannot be completely excluded.  More information such as laboratory findings on viral nucleic acid /PCR test needed for meaningful medical assessment.
Low grade fever 99.9 and aches and back pain and chills and headache and rash in armpit neck and shoulder areas bilaterally.
Spouse reported that patient was taken to The Hospital after unresponsive in the home on 4/2/2021.  States was told that cause of death was heart failure.
Headache, Myalgia, Fever, SkinRash, CoughWheeze, Skin redness, fatigue, chills Narrative:
After receiving vaccine #2 had itching under arms (bilateral), spreading downward to hands and torso. Seen by PCP. Took steroids. Resolved in 4 weeks. Patient notified us on 3-22-11.
Patient received Fluad at pharmacy and was instructed to get the HD from MD.  She tried to confirm with the team multiple times.  However, MD(s) and patients are referring to the special >=65y/o shot as "HD".  The vaccinating technician confirmed 65 and up shot.  The patient was upset and spoke witht he pharmacist a few days later.  I explained that the HD and Fluad are non-superior and it doesn't matter which one.  I instructed patient to confirm with md she was given Fluad and he/she would likely be satisfied and confirm my knowledge.  Patient called MD and read paperwork and they thought it was the regular shot.  They gave her the HD in office a few days later.  I called MD confirmed that either shot would have been fine but they maintain the patient stated she got the "regular" shot so they gave the HD.  My acting DM recommended we fill out this form.
CG received 2nd Covid Vaccine 1/11/2021; S/Sx Vertigo,,dizzy,,foggy feeling,generalized malaise on 1/12/21. on 1/13/21 felt near normal. Then 1/14/21 ,almost passed out on way to work,foggy feeling,vertigo,dizzy & therefore called in sick for today,1/14/21.  . Vertigo, loss of balance, extreme malaise, near syncopal episodes.  . I continued to have neurological symptoms both days. Vertigo, loss of balance, extreme malaise, near syncopal episodes. . 1/20: I continued to have neurological symptoms both days. Vertigo, loss of balance, extreme malaise, near syncopal episodes on 1/15.
wheezing; Entire body aches; coughing; lymph nodes in the left arm out are swollen; head hurts; Exhausted; This is a spontaneous report from a contactable consumer (patient). A 47-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19  VACCINE, Solution for injection; lot number and expiration date: not reported), via an unspecified route of administration, in the right arm on 22Mar2021 at 18:15 (at the age of 47-year-old) as dose 1, single  for COVID-19 immunization. Medical history included COVID-19. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 23Mar2021 at 07:00, the patient's lymph nodes in her left arm out were swollen. The patient had entire body aches. The patient was wheezing and coughing. Her head was hurting and was exhausted. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events . The outcome of the events was not recovered at the time of the report..   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
CHILLS; HEADACHE; FEVER; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 18-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On MAR-2021, the subject experienced chills. On MAR-2021, the subject experienced headache. On MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills, headache and fever was not reported. This report was non-serious. This case, from the same reporter is linked to 20210345602.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a 64 year old male patient. Information on the patient's concurrent conditions, medical history or concomitant therapy was not reported.     On 11-JAN-2013, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, lot# and expiration date were not reported). On 13-JUL-2013, as a result of his receipt of zoster vaccine live (ZOSTAVAX), the patient was caused to suffer shingles, including any and all of its sequelae. As a result of zoster vaccine live (ZOSTAVAX), patient has been caused to suffer severe personal injuries, pain, suffering, and emotional distress, as well as to incur substantial economic damages. As a result of the foregoing acts and omissions, patient was caused to suffer serious and dangerous side effects including shingles, as well as other severe and personal injuries which are permanent and lasting in nature, physical pain and mental anguish, including diminished enjoyment of life, as well as the need for lifelong medical treatment, monitoring and/or medications. As a result of the foregoing acts and omissions, patient requires and/or will require more health care and services and did incur medical, health, incidental and related expenses. The outcome of shingles was reported as not recovered/not resolved. The reporter considered shingles to be related to Zoster Vaccine Live(ZOSTAVAX).     Shingles was considered to be disabling.
Weakness, nausea, vomiting, headache, hot flashes, joint pain and swelling.
Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: PT COMPLAINS OF GENERAL BODY ACHES, PAIN AND SWELLING IN JOINTS, REDNESS ALL OVER BODY-Mild, Systemic: Flushed / Sweating-Severe, Systemic: Joint Pain-Severe, Systemic: Lymph Node Swelling-Severe
Information has been received from a registered nurse concerning a patient who at 8 months and 28 days was vaccinated orally with the third 2 ml dose of ROTATEQ (lot # not reported). No adverse effect reported. No further information is available.
This is ridiculous, what happened had nothing to do with the vaccine.  I'm only doing this because this happened after the shot but I'm sure it was unrelated.  I had a bad gout flare up.  It lasted several weeks.  I had to do 2 courses of Prednisone to clear it up.
SOB, back pain and chest pain 1-2 minutes after administration. called 911 and sent the patient to the hospital to get it checked out.
Rash on limbs within 24 hours of receiving ADACEL inj. Lasted 6 days before pt presented to office. Treated with tapering dose of Prednisone 20mg resolved within 2 days of starting medication.
ACUTE NON ST ELEVATION MI 6/16/2022,  1/14/2023,  1/10/2023  --  RECURRENCE OF SAME SYMPTOMS
Abdominal pain and fever of 101F following 2nd dose of rabies post exposure prophylaxis. Completed series without further sx.
boosted adult traveler acquired COVID-19 after returning; boosted adult traveler acquired COVID-19 after returning; This is a literature report.  An adult patient received BNT162b2 (BNT162B2), on 01Mar2021 as dose 1, single (Batch/Lot number: unknown), on 22Mar2021 as dose 2, single (Batch/Lot number: unknown) and on 06Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "recovered" and all described as "boosted adult traveler acquired COVID-19 after returning". Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical courses: Boosted adult traveler acquired COVID-19 after returning and was treated with NM/r 300/100 mg taken orally twice daily for 5 days. Casee resolved quickly.; Sender's Comments: Based on the compatible time association, the lack of efficacy cannot be excluded for suspect vaccine BNT162B2 administration.
Pfizer-BioNTech COVID-19 Vaccine EUA: patient developed soreness around injection site,  chills, and fever in the evening following  vaccine administration. The next day developed rash, itching, and mild swelling below eyelids. Three days after vaccination patient reported tongue appeared red, bumpy, and a little swollen. Patient took diphenhydramine with some improvement overnight, then cetirizine the following day. It took another 24 hours- five days from vaccination- for tongue bumps and swelling to resolve.
940AM as pt began to leave facility started to feel dizzy w/dry mouth & trouble swallowing;MD notified & noticed pt to be diaphoretic w/sl swelling to post pharynx;epi given;
Had AFib a couple days after receiving first shot of the Moderna vaccine. Heart felt like it was beating out of my chest, took a EKG on my watch, and it said that I had AFib heart rhythm.
NO ADVERSE EVENT; PT RECEIVED VACCINE UNDER THE RECOMMEND AGE. PATIENT IS 17 YEARS OLD.
I was at an event at a cafe the weekend prior to getting sick.  I started to have a slight cough and upper respiratory reactions.  The next day it continued so I took a at home test, and it was positive.  On the 23rd of January I had symptoms.  I notified my doctor to setup a visit via telehealth, NP.  They did not say I was a good fit for Paxlovid since my other medications.  The prescribed Levario.  I took that as directed.  I did have some reactions to the antiviral; it included vomiting and abdominal distress.  I am still testing postive and I still have a very slight cough.
PT DEVELOPED NAUSEA, VOMITING, SEVERE BODY ACHES, SWOLLEN ARM, FATIGUE
First Vaccination on 01/13/21  right arm -  pain at injection site for several days following.  Brain fog and some fatigue. Second vaccination on 02/3/21 left arm -    approx. 3 hours later felt a little woosie  and spacey.  Pain at injection site.  At approx. 3am the following morning experiencing  chills and body jerks along with long deep breathing.  Temperature 100.1.  Also had a painful headache and full body aches along with some nausea and very fatigued and pain at injection site was growing in size and was also hot and red and swollen.  Contacted primary care doctor about these side effects.  On 2/5/21 the  temperature reached 100.7 and the  previous days aliments  continued and fever came down to 99.6.  Lots on pain in left side of neck and left arm.  Let arm continues to be swollen, red and hot and is itchy.   Fever finally broke on the night on Feb. 6th.
started having "uncontrollable movements" R arm that same year  and R ankle "locking up" sometime in July,2015. Unknown outcome went to unknown neurologist for treatment.
High fever; This case was reported by a nurse via sales rep and described the occurrence of fever in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced fever. On an unknown date, the outcome of the fever was unknown.   It was unknown if the reporter considered the fever to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient had high fever after Shingrix vaccination.
Patient had redness and swelling to the site of where varicella was administered minutes after vaccine was given. Patient complained of pain to site and site felt hot to touch.
Fever 99.5 the next day; Sore arm; Occasionally felt fatigue, tired; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 12May2021 at 13:15 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patients' medical history was reported as none. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food or other products. Concomitant medications included benazepril (MANUFACTURER UNKNOWN) for an unspecified indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 21Apr2021 at 10:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 12May2021, the patient experienced sore arm for three days and the patient occasionally felt fatigue, tired for about 2-3 hours which would then wear off. On 13May2021, the next day of the vaccination, the patient experienced a fever of 99.5 (unspecified units). Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event fever 99.5 (unspecified units) the next day and felt fatigue, tired was resolving at the time of this report. The clinical outcome of the event sore arm was resolved on 15May2021.  No follow-up attempts are needed. No further information is expected.
Minor, but only started  6 days after vaccine. Itching and redness , slight swelling, appearing to be contained within the muscle of the injection. No pain. Worse at end of the day, night. Tolerable. Ongoing currently, not spreading, not worsening. Reporting for information only.
Pain continued at injection site. Denies numbness/tingling/paresthesia/loss of grip strength. No erythema or swelling noted.
A report was received from a health care professional on 12/2/03 concerning a female vaccine (age unspecified) who experienced local pain and later developed right shoulder arthritis/bursitis after she received Fluvirin on 10/28/03. On 10/28/03, the vaccinee received Fluvirin into the right arm 1cm below the right shoulder joint. The vaccinee experienced local pain at the time of the vaccination. The vaccinee later developed right shoulder arthritis/bursitis that had not resolved at the time of reporting. The vaccinee was referred to an orthopedic surgeon for follow up. The reporter stated that the Fluvirin injection might possibly have been administered into the shoulder joint. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
NASAL CONGESTION, CHEST CONGESTION, COUGH, BODY ACHES, FEVER
This spontaneous report as received from an unspecified administrator refers to a patient of unknown demographics. Patient's pertinent medical history, concurrent condition and concomitant medication were not reported. No previous drug reactions/allergies were reported. On 21-OCT-2016, the patient was vaccinated with an expired dose of (Oka/Merck) VARIVAX (lot # K018964, expiry date 15-OCT-2016 (strength, dosing details and anatomical location were unknown). No adverse effects were reported. No product quality complaint was involved. Additional information has been requested.
SWELLING BEHIND HER KNEE, CALF AND THIGH; PAIN BEHIND HER KNEE, CALF AND THIGH; CHILLS; NAUSEA; FEVER; INJECTION SITE PAIN; DIZZINESS; DIFFICULT TIME GETTING UP AND MOVING; HEADACHE/COULD NOT MOVE OR TALK; This spontaneous report received from a parent concerned a 20 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included asthma, non smoker, and non-alcoholic, and other pre-existing medical conditions included the patient had no known allergies. the patient had no history of drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: UNKNOWN) dose was not reported, administered on 01-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced difficult time getting up and moving. On APR-2021, the subject experienced headache/could not move or talk. On 01-APR-2021, the subject experienced dizziness. On 01-APR-2021, the subject experienced chills. On 01-APR-2021, the subject experienced nausea. On 01-APR-2021, the subject experienced fever. On 01-APR-2021, the subject experienced injection site pain. On 11-APR-2021, the subject experienced swelling behind her knee, calf and thigh. On 11-APR-2021, the subject experienced pain behind her knee, calf and thigh. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and fever on 04-APR-2021, injection site pain on 03-APR-2021, and headache/could not move or talk on APR-2021, was recovering from nausea, and dizziness, had not recovered from pain behind her knee, calf and thigh, and swelling behind her knee, calf and thigh, and the outcome of difficult time getting up and moving was not reported. This report was non-serious.; Sender's Comments: V0: Medical Assessment comment was not required as per standard procedure as the case assessed as non-serious.
Patient woke up at 2 am (10 hours after vaccination) and felt tightness in her throat. She took 1 Benadryl and was feeling better and was able to go back to sleep. At 2 pm, 12 hours later, she felt the tightness again and took 1 Benadryl. Patient said she did not want the pharmacy to contact her doctor but she will talk to her doctor this week at her physical.
BODY ACHES; LUMP AT INJECTION SITE; CHILLS; JOINT PAIN; FEVER; HEADACHE; SWELLING AT INJECTION SITE; ARM PAIN AT INJECTION SITE; This spontaneous report received from a patient concerned a 54 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included seasonal allergies, and unspecified food allergy, and other pre-existing medical conditions included patient had not asked drug abuse or illicit drug usage, alcohol use and smoke. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number: 1802068 expiry: 25-MAY-2021) dose was not reported, administered on 25-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 25-MAR-2021, the subject experienced body aches. On 25-MAR-2021, the subject experienced lump at injection site. On 25-MAR-2021, the subject experienced chills. On 25-MAR-2021, the subject experienced joint pain. On 25-MAR-2021, the subject experienced fever. On 25-MAR-2021, the subject experienced headache. On 25-MAR-2021, the subject experienced swelling at injection site. On 25-MAR-2021, the subject experienced arm pain at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, chills, joint pain, fever, headache, and arm pain at injection site on 28-MAR-2021, was recovering from swelling at injection site, and the outcome of lump at injection site was not reported. This report was non-serious.